Jeppson Wealth Management’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$922K Hold
6,038
0.29% 82
2025
Q4
$832K Hold
6,038
0.26% 88
2025
Q3
$774K Sell
6,038
-10
-0.2% -$1.22K 0.25% 90
2025
Q2
$732K Sell
6,048
-30
-0.5% -$3.38K 0.25% 88
2025
Q1
$678K Hold
6,078
0.25% 93
2024
Q4
$591K Sell
6,078
-275
-4% -$29.3K 0.21% 106
2024
Q3
$731K Hold
6,353
0.26% 92
2024
Q2
$676K Buy
6,353
+40
+0.6% +$4.01K 0.26% 90
2024
Q1
$611K Sell
6,313
-64
-1% -$6.56K 0.24% 101
2023
Q4
$644K Hold
6,377
0.27% 92
2023
Q3
$650K Sell
6,377
-100
-2% -$10.2K 0.3% 84
2023
Q2
$654K Sell
6,477
-405
-6% -$40.5K 0.28% 88
2023
Q1
$633K Buy
6,882
+134
+2% +$11.7K 0.28% 92
2022
Q4
$612K Buy
6,748
+1,052
+18% +$88.6K 0.26% 90
2022
Q3
$433K Buy
5,696
+905
+19% +$75K 0.2% 111
2022
Q2
$405K Buy
+4,791
New +$420K 0.17% 112
2020
Q4
Sell
-600
Closed -$52K 344
2020
Q3
$52K Buy
+600
New +$52K 0.04% 219

Other funds holding NVS

Jeppson Wealth Management's NVS Position: Q1 2026 in Review

Jeppson Wealth Management held its Novartis (NVS) position steady in Q1 2026 at 6,038 shares worth $922K. The position accounts for 0.29% of the portfolio, ranked #82.

Jeppson Wealth Management first reported a position in NVS in Q3 2020 and has held it in 17 quarters since. 1,590 funds tracked by Wall St. Rank hold NVS as of Q1 2026.

  • Jeppson Wealth Management held 6,038 shares of Novartis worth $922K as of Q1 2026.
  • Jeppson Wealth Management left its Novartis share count unchanged in Q1 2026.
  • Novartis made up 0.29% of Jeppson Wealth Management's portfolio in Q1 2026, its #82 holding.
  • Jeppson Wealth Management first reported a position in Novartis in Q3 2020 and has held it in 17 quarters since.
  • 1,590 funds tracked by Wall St. Rank held Novartis as of Q1 2026.

Based on Jeppson Wealth Management's 13F filing for Q1 2026, filed 14 Apr 2026.